← Back to Conditions

Phosphoenolpyruvate carboxykinase (GTP) deficiency

disorder
SNOMED 5335002CUI C0268194

Overview

Phosphoenolpyruvate carboxykinase (GTP) deficiency is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Hypoglycemic episodes
Very frequent (80-99%)HP:0001988
Alanine aminotransferase increased
Frequent (30-79%)HP:0031964
Elevated serum aspartate aminotransferase
Frequent (30-79%)HP:0031956
Elevated urine fumaric acid level
Frequent (30-79%)HP:0034648
High plasma glutamine
Frequent (30-79%)HP:0003217
Higher than normal levels of lactate in blood
Frequent (30-79%)HP:0002151
Hypoglycemic seizures
Frequent (30-79%)HP:0002173
Increased urine alpha-ketoglutarate concentration
Frequent (30-79%)HP:0012402
Increased urine lactate
Frequent (30-79%)HP:0003648
Lacticacidosis
Frequent (30-79%)HP:0003128
Acute encephalopathy
Occasional (5-29%)HP:0006846
Dullness
Occasional (5-29%)HP:0001254
Fatty liver
Occasional (5-29%)HP:0001397
Hepatopathy
Occasional (5-29%)HP:0001410
Hypoglycemic coma
Occasional (5-29%)HP:0001325
Muscular hypotonia
Occasional (5-29%)HP:0001252
Neonatal hypoglycemia
Occasional (5-29%)HP:0001998
Neurodevelopmental delay
Occasional (5-29%)HP:0012758
Sleepy
Occasional (5-29%)HP:0002329
Vomiting
Occasional (5-29%)HP:0002013
Decreased size of cranium
Very rare (1-4%)HP:0000252
High blood ammonia levels
Very rare (1-4%)HP:0001987

Quick Facts

SNOMED CT
5335002
UMLS CUI
C0268194
Fully Specified Name
Phosphoenolpyruvate carboxykinase deficiency (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
22
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.